News

Read the latest.

Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats

Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats

All News Press Releases

Apriori Receives Grant Extension from CEPI to Further Advance Octavia™ Platform

Apriori Bio and A*STAR Infectious Diseases Labs Announce Strategic Partnership to Advance Next Generation Influenza Vaccines

Apriori Bio Announces Collaboration with the Francis Crick Institute

Flagship Pioneering Appoints Craig Williams as CEO-Partner and Chief Executive Officer of Apriori Bio

Apriori Bio Appoints Harry Kleanthous, Ph.D., as Chief Scientific Officer

Apriori Bio Appoints World-Class Vaccine, Immunology and Public Health Leaders to Board of Directors